MYD88 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.906000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.317800E-01
Normal-vs-Stage2
6.065000E-01
Normal-vs-Stage3
1.051040E-01
Normal-vs-Stage4
9.367800E-01
Stage1-vs-Stage2
2.347200E-01
Stage1-vs-Stage3
4.899000E-01
Stage1-vs-Stage4
2.944000E-01
Stage2-vs-Stage3
6.376400E-02
Stage2-vs-Stage4
4.563000E-01
Stage3-vs-Stage4
1.334400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.617000E-01
Normal-vs-AfricanAmerican
4.239400E-01
Normal-vs-Asian
9.921400E-01
Caucasian-vs-AfricanAmerican
7.105800E-01
Caucasian-vs-Asian
1.766620E-01
AfricanAmerican-vs-Asian
2.692400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.051200E-01
Normal-vs-Female
4.692400E-01
Male-vs-Female
8.819400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.525000E-01
Normal-vs-Age(41-60Yrs)
7.177400E-01
Normal-vs-Age(61-80Yrs)
3.923200E-01
Normal-vs-Age(81-100Yrs)
6.022100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.659400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.657000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.406600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.005450E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.398000E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.765180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.626400E-01
Normal-vs-Daily Drinker
5.846800E-01
Normal-vs-Weekly Drinker
5.334800E-01
Normal-vs-Occasional Drinker
6.998000E-01
Normal-vs-Social Drinker
3.485000E-01
Non Drinker-vs-Daily Drinker
9.264600E-01
Non Drinker-vs-Weekly Drinker
8.346400E-01
Non Drinker-vs-Occasional Drinker
5.162000E-01
Non Drinker-vs-Social Drinker
8.984400E-01
Daily Drinker-vs-Weekly Drinker
9.028400E-01
Daily Drinker-vs-Occasional Drinker
5.837200E-01
Daily Drinker-vs-Social Drinker
8.266600E-01
Weekly Drinker-vs-Occasional Drinker
6.511200E-01
Weekly Drinker-vs-Social Drinker
6.868200E-01
Occasional Drinker-vs-Social Drinker
3.646200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.099000E-01
Normal-vs-Grade 2
5.697700E-02
Normal-vs-Grade 3
8.467600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.52329999999679E-05
Grade 1-vs-Grade 3
3.600100E-04
Grade 1-vs-Grade 4
5.099000E-01
Grade 2-vs-Grade 3
9.535400E-01
Grade 2-vs-Grade 4
5.697700E-02
Grade 3-vs-Grade 4
8.467600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.025000E-01
Normal-vs-NonDiabetic
4.743600E-01
Diabetic-vs-NonDiabetic
9.661800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.582000E-01
Normal-vs-NoPancreatitis
4.562400E-01
Pancreatitis-vs-NoPancreatitis
3.206600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.463400E-01
Normal-vs-N1
5.824800E-01
N0-vs-N1
2.360600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.745800E-01
Normal-vs-TP53-NonMutant
1.276590E-01
TP53-Mutant-vs-TP53-NonMutant
1.71356999999484E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
